RECEPTORS-MEDIATED DELIVERY OF GENES BY USING VECTORS BASED UPON BACTERIOPHAGES Russian patent published in 2003 - IPC

Abstract RU 2209088 C2

FIELD: medicinal genetics. SUBSTANCE: the present innovation deals with filamentous phage particles with ligands on their surface. These particles are used to deliver therapeutic gene to cells. Ligand is the protein developed at fusion to phage capsid protein covalently conjugated with phage particles. EFFECT: increased number of gene therapeutic preparations. 45 cl, 9 dwg, 9 ex, 1 tbl

Similar patents RU2209088C2

Title Year Author Number
METHOD FOR IDENTIFICATION OF BACTERIOPHAGE, METHOD FOR ISOLATION OF MAMMAL CELLS, METHOD FOR SELECTION OF BACTERIOPHAGE (VARIANTS), METHOD FOR IDENTIFICATION OF BACTERIOPHAGE SUBGROUP AND INTERNALIZING LIGAND (VARIANTS) 1998
  • Larokka Dehvid
RU2234530C2
MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE 1995
  • Kehmb Aleksandr
RU2164419C2
RECEPTOR BODY SPECIFICALLY BINDING LIGAND TIE-2, ISOLATED NUCLEIC ACID MOLECULE, PLASMID, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION OR ATTENUATION OF NEOVASCULARIZATION IN MAMMALS 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2216593C2
ISOLATED NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR PREPARING, PLASMID (VARIANTS), ANTIBODY, CONJUGATE, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR STIMULATING NEO-VASCULARIZATION, METHOD FOR CELL MAINTENANCE, METHOD FOR IDENTIFYING TIE-2 RECEPTOR ANTAGONIST 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2232812C2
NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR ITS PREPARING, VECTOR, STRAIN OF CELLS COS, ANTIBODY, CONJUGATE OF LIGAND TIE-2, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS OR ATTENUATION OF NEOVASCULARIZATION AND METHOD FOR IDENTIFICATION OF TIE-2 RECEPTOR ANTAGONIST 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2233330C2
IMPROVED ANTI-IGE-ANTIBODY (VARIANTS) AND METHOD FOR IMPROVING POLYPEPTIDES 1998
  • Louman Khenri B.
  • Presta Leonard G.
  • Zhard'E Paula M.
  • Lou Dzhon
RU2242515C2
FUSED POLYPEPTIDE ABLE TO PURPOSEFUL TRANSFER TO OILY BODY, CHIMERIC DNA-CONSTRUCTION, EXPRESSING CASSETTE 1992
  • Moloni Moris
RU2201449C2
DNA MUTAGENESIS BY DISORDERED FRAGMENTATION AND SECONDARY ASSEMBLY 1995
  • Villem P.S. Stemmer
  • Andreas Krameri
RU2157851C2
MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS 1995
  • Skol'Nik Mark Kh.
  • Kennon-Ehlbrajt Lajza A.
  • Kehmb Aleksandr
RU2161309C2
HUMANISED ANTI-CD40-ANTIBODIES AND METHODS OF APPLICATION THEREOF 2006
  • Presta Leonard G.
  • O'Konnell Lori J.
  • Doronina Svetlana O.
RU2407544C2

RU 2 209 088 C2

Authors

Larokka Dehvid

Behjrd Ehndrju

Dzhonson Uehndi

Dates

2003-07-27Published

1998-08-28Filed